These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 7597655)

  • 1. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral contraceptives in pregnancy and major structural birth defects in offspring.
    Waller DK; Gallaway MS; Taylor LG; Ramadhani TA; Canfield MA; Scheuerle A; Hernández-Diaz S; Louik C; Correa A;
    Epidemiology; 2010 Mar; 21(2):232-9. PubMed ID: 20087193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Epidemiology; 1995 May; 6(3):212-8. PubMed ID: 7619925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal history of subfertility and the risk of congenital urinary tract anomalies in offspring.
    Li DK
    Epidemiology; 1999 Jan; 10(1):80-2. PubMed ID: 9888285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electric blanket use during pregnancy in relation to the risk of congenital urinary tract anomalies among women with a history of subfertility.
    Li DK; Checkoway H; Mueller BA
    Epidemiology; 1995 Sep; 6(5):485-9. PubMed ID: 8562623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital abnormalities in the offspring of women who used oral and other contraceptives around the time of conception.
    Harlap S; Shiono PH; Ramcharan S
    Int J Fertil; 1985; 30(2):39-47. PubMed ID: 2865223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
    Holly EA; Weiss NS; Liff JM
    J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal risk factors for congenital urinary anomalies: results of a population-based case-control study.
    Shnorhavorian M; Bittner R; Wright JL; Schwartz SM
    Urology; 2011 Nov; 78(5):1156-61. PubMed ID: 22054394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal use of oral contraceptives during early pregnancy and risk of hypospadias in male offspring.
    Nørgaard M; Wogelius P; Pedersen L; Rothman KJ; Sørensen HT
    Urology; 2009 Sep; 74(3):583-7. PubMed ID: 19592074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periconceptional exposure to contraceptive pills and risk for Down syndrome.
    Martínez-Frías ML; Bermejo E; Rodríguez-Pinilla E; Prieto L
    J Perinatol; 2001; 21(5):288-92. PubMed ID: 11536021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical exposures during pregnancy and congenital cardiovascular malformations.
    Judge CM; Chasan-Taber L; Gensburg L; Nasca PC; Marshall EG
    Paediatr Perinat Epidemiol; 2004 Sep; 18(5):352-60. PubMed ID: 15367322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid contraceptive use and pregnancy outcome.
    Pardthaisong T; Gray RH; McDaniel EB; Chandacham A
    Teratology; 1988 Jul; 38(1):51-8. PubMed ID: 2845595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptives and the conceptus. I. Chromosome abnormalities of the fetus and neonate related to maternal contraceptive history.
    Klinger HP; Glasser M; Kava HW
    Obstet Gynecol; 1976 Jul; 48(1):40-8. PubMed ID: 934573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to DMPA in pregnancy may cause low birth weight.
    Prog Hum Reprod Res; 1992; (23):2-3. PubMed ID: 12286194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.